Boston Scientific discloses HHS probe into Cognis, Teligen ICDs

Boston Scientific discloses a U.S. Health & Human Services Dept. subpoena over its Cognis and Teligen implantable cardiac defibrillators.

Boston Scientific (NYSE:BSX) said it received a subpoena from the U.S. Health & Human Services Dept. over its Cognis and Teligen implantable cardiac defibrillators.

Boston Scientific, Dept. of Health & Human Services (HHS)

Legal News, News Well, Cardiac Rhythm Management

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1g3uAUW